Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 12 | 2011 | 2445 | 2613 | 93.6% | |
| STROKE 12 | 2012 | 2436 | 2621 | 92.9% | |
| STROKE 12 | 2013 | 2370 | 2542 | 93.2% | |
| STIA007 | 2014 | 2461 | 2531 | 97.2% | |
| STIA007 | 2015 | 2497 | 2612 | 95.6% | |
| STIA007 | 2016 | 2541 | 2636 | 96.4% | |
| STIA007 | 2017 | 2565 | 2653 | 96.7% | |
| STIA007 | 2018 | 3037 | 3112 | 97.6% | |
| STIA007 | 2019 | 3152 | 3203 | 98.4% | |
| STIA007 | 2020 | 3202 | 3329 | 96.2% | |
| STIA007 | 2021 | 3217 | 3512 | 91.6% | |
| STIA007 | 2022 | 3439 | 3556 | 96.7% | |
| STIA007 | 2023 | 3536 | 3653 | 96.8% |
